Browsing by Author Connor, Mark

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 34  next >
Issue DateTitleAuthor(s)Citation
2016The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activitiesBanister, Samuel; Kassiou, Michael; Longworth, Mitchell; Connor, Mark; Glass, Michelle; Mack, James B.C.; Medical Radiation Sciences; Chemistry; ChemistryThe 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities, Forensic Toxicology, vol.34, 2, 2016,pp 286-303
2002Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neuronsChristie, MacDonald; Connor, Mark; Roberts, Louise; Northern Clinical School: Anaesthesia; Central Clinical School: Brain & Mind Research Institute; School of Medical Sciences: PharmacologyAnandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons, British Journal of Pharmacology, vol.137,(4),2002,pp 421-428
2015beta-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neuronsBagley, Elena; Chieng, Billy Chin Hak; Christie, MacDonald; Connor, Mark; School of Medical Sciences: Brain and Mind Centre; School of Medical Sciences: Brain and Mind Centre; School of Medical Sciences: Pharmacologybeta-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons, British Journal of Pharmacology, vol.172, 2, 2015,pp 492-500
2002Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitroChristie, MacDonald; Connor, Mark; Marinelli, Silvia; Vaughan, Christopher W.; Northern Clinical School: Anaesthesia; Central Clinical School: Brain & Mind Research InstituteCapsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro, Journal of Physiology, vol.543,(2),2002,pp 531-540
2004Cellular Actions Of Somatostatin On Rat Periaqueductal Grey Neurons In VitroBagley, Elena; Christie, MacDonald; Connor, Mark; Mitchell, Vanessa; Vaughan, Christopher; Humphrey, Patrick P.A.; Ingram, Susan L.; Northern Clinical School: Pain Mgt. Res. Inst.; Northern Clinical School: Anaesthesia; Central Clinical School: Brain & Mind Research Institute; Northern Clinical School: Anaesthesia; Northern Clinical School: MedicineCellular Actions Of Somatostatin On Rat Periaqueductal Grey Neurons In Vitro, British Journal of Pharmacology, vol.142,(8),2004,pp 1273-1280
2013A Continuous, Fluorescence-based Assay of u-Opioid Receptor Activation in AtT-20 CellsChristie, MacDonald; Du, Yan; Bennallack, Philip; Connor, Mark; Knapman, Alisa; Santiago, Marina; School of Medical Sciences: Pharmacology; Northern Clinical School: AnaesthesiaA Continuous, Fluorescence-based Assay of u-Opioid Receptor Activation in AtT-20 Cells, Journal of Biomolecular Screening, vol.18, 3, 2013,pp 269-276
2005Contrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat.Connor, Mark; McCleskey, Edwin W.; Naves, Ligia A.; Central Clinical School: Brain & Mind Research InstituteContrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat., Molecular Pain, vol.1,(N/A),2005,pp 31-43
2003Convulsant actions of CalycanthineCollins (Chebib), Mary; Connor, Mark; Duke, Colin; Duke, Rujee; Johnston, Graham; Mewett, Kenneth; Pharmacy; Northern Clinical School: Medicine; Pharmacy; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyConvulsant actions of Calycanthine, Toxicology and Applied Pharmacology, vol.190,(1),2003,pp 58-64
2006Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.Chieng, Chin (Billy); Connor, Mark; Johnson, Emma; Napier, Ian; Northern Clinical School: Anaesthesia; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: AnaesthesiaDecreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice., British Journal of Pharmacology, vol.148,(7),2006,pp 947-955
2005delta-OPIOID RECEPTOR-MEDIATED ACTIONS ON ROSTRAL VENTROMEDIAL MEDULLA NEURONSChristie, MacDonald; Connor, Mark; Marinelli, S; Vaughan, Christopher; Schnell, Stephen A.; Wessendorf, Martin W.; Northern Clinical School: Anaesthesia; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicinedelta-OPIOID RECEPTOR-MEDIATED ACTIONS ON ROSTRAL VENTROMEDIAL MEDULLA NEURONS, Neuroscience 2005, vol.132,(2),2005,pp 239-244
2015Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135Banister, Samuel; Beinat, Corinne; Hibbs, David; Kassiou, Michael; Kevin, Richard; Longworth, Mitchell; McGregor, Iain; Wilkinson, Shane; Buchanan, Alexandra; Connor, Mark; Edington, Amelia; Glass, Michelle; Stuart, Jordyn; Chemistry; Chemistry; Pharmacy; Medical Imaging and Radiation Sciences; Psychology; Chemistry; Psychology; ChemistryEffects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135, ACS Chemical Neuroscience, vol.6, 8, 2015,pp 1445-1458
2016Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptorsGulliver, Damien; Jorgensen, William Thomas; Kassiou, Michael; Reekie, Tristan Andrew; Werry, Eryn; Connor, Mark; School of Medical Sciences: Pharmacology; Chemistry; Medical Imaging and Radiation Sciences; Medical Imaging and Radiation Sciences; Medical Imaging and Radiation SciencesFlexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors, European Journal of Medicinal Chemistry, vol.108, N/A, 2016,pp 730-740
2002Gingerols: a novel class of vanilloid receptor (VR1) agonistsChristie, MacDonald; Connor, Mark; Dedov, Vadim; Duke, Colin; Mandadi, Sravan; Roufogalis, Basil; Tran, Van; Northern Clinical School: Anaesthesia; Northern Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Pharmacy; Key Centre - Microscopy; Pharmacy; PharmacyGingerols: a novel class of vanilloid receptor (VR1) agonists, British Journal of Pharmacology, vol.137,(6),2002,pp 793-798
2012Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HTConnor, Mark; Gilmore, Andrew; Kassiou, Michael; Reynolds, Aaron; Heblinski, Marika; School of Medical Sciences: Brain & Mind Research Institute; Northern Clinical School: Kolling Institute; Medical Imaging and Radiation Sciences; ChemistryInhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT, British Journal of Pharmacology, vol.167, 5, 2012,pp 1076-1088
2009Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamineConnor, Mark; Gilmore, Andrew; Ross, Hamish; School of Medical Sciences: Brain & Mind Research Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineInhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine, British Journal of Pharmacology, vol.156, 5, 2009,pp 740-750
2008Inhibition of recombinant human t-type calcium channels by delta 9-tetrahydrocannabinol and cannabidiolConnor, Mark; Napier, Ian; Ross, Hamish; School of Medical Sciences: Brain & Mind Research Institute; School of Medical Sciences: Pharmacology; Northern Clinical School: MedicineInhibition of recombinant human t-type calcium channels by delta 9-tetrahydrocannabinol and cannabidiol, Journal of Biological Chemistry, vol.283, 23, 2008,pp 16124-16134
2017Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonistsGulliver, Damien; Jorgensen, William Thomas; Kassiou, Michael; Katte, Timothy; Reekie, Tristan Andrew; Werry, Eryn; Wong, Erick; Boyd, Rochelle; Connor, Mark; School of Medical Sciences: Pharmacology; Chemistry; Chemistry; Chemistry; Medical Imaging and Radiation Sciences; Medical Imaging and Radiation Sciences; School of Medical Sciences: PharmacologyInvestigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists, European Journal of Medicinal Chemistry, vol.136, N/A, 2017,pp 330-333
2007Lack of functional expression of NMDA receptors in PC12 cellsConnor, Mark; Edwards, Mark A; Loxley, Rhonda A; Phillips, Jacqueline K.; Williams, Andrew J; Northern Clinical School: MedicineLack of functional expression of NMDA receptors in PC12 cells, NeuroToxicology, vol.28,(4),2007,pp 876-885
2008Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitroConnor, Mark; Roberts, Louise; Ross, Hamish; School of Medical Sciences: Brain & Mind Research Institute; School of Medical Sciences: Pharmacology; Northern Clinical School: MedicineMethanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro, Neuropharmacology, vol.54, 1, 2008,pp 172-180
2004Mu-Opioid Receptor Desentization: Is Morphine Different?Christie, MacDonald; Connor, Mark; Osborne, Peregrine; Northern Clinical School: Anaesthesia; Northern Clinical School: Medicine; Northern Clinical School: MedicineMu-Opioid Receptor Desentization: Is Morphine Different?, British Journal of Pharmacology, vol.143,(6),2004,pp 685-696